Search results

Narrow your search

Result types

Showing 411 - 420 of 569 for "Hong Kong SAR" with applied filters

News & Analysis

COVID-19 与不可抗力相关规定在香港的执行

29 April 2020 by Asia law

在本文中,合伙人高嘉力(Nick Gall),陈琬琳 (Evelyn Chan),袁佩筠(Kenix Yuen)和见习律师黄殷怀 (Adriel Wong) 探讨不可抗力条款是否适用于COVID-19和當事方的履约,以及当事方认为有权采取的各种行动调用不可抗力条款。

News & Analysis

asialaw Client Service Excellence 2020: The highest rated lawyers to work with

29 April 2020 by Asia law

The most successful lawyers go to great lengths to ensure they provide their clients with consistent and high quality service.

News & Analysis

asialaw Client Service Excellence 2020: The highest rated firms to work with

29 April 2020 by Asia law

The most successful law firms and lawyers go to great lengths to ensure they provide their clients with consistent and high quality service.

News & Analysis

CC, KWM, Linklaters, JunHe act on first dim sum bonds to fight Covid-19

17 April 2020 by Asia law

The first dim sum bonds to raise funds to help fight the COVID-19 crisis

News & Analysis

Beijing, HK and Macau firms form an association in Shenzhen

14 April 2020 by Asia law

The first joint association of firms within the Greater Bay Area

News & Analysis

DEAL OF THE MONTH - March 2020

07 April 2020 by Asia law

asialaw's Deal of the Month for March 2020 is...

News & Analysis

LEGAL DEALS ROUNDUP - March 2020

07 April 2020 by Asia law

asialaw's picks of the most significant legal matters in the region in March 2020

News & Analysis

Hong Kong Oldham Li & Nie in association with Watson & Band

06 April 2020 by Asia law

The association aims to approach clients uniquely with both domestic and global perspectives

News & Analysis

An overview on private mergers and acquisitions in Hong Kong

03 April 2020 by Asia law

Public mergers and acquisitions (“M&A”) transactions often receive a lot of publicity. Nevertheless, there is no shortage of activities in private M&A. In Hong Kong, there are two main types of acquisition in the private M&A space: (1) purchase of shares of a private company and (2) asset purchase.

News & Analysis

Commerce & Finance and Davis Polk advise InnoCare Pharma on its IPO in HK

03 April 2020 by Asia law

This is the largest IPO in Q1 on the HKEX